Drreddys Laboratories | RDY - الأصول





الأصول تغيير تاريخ
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Canopy Growth CAD 1.12B 12.54M 2026-03
Cipla INR 424.96B 23.32B 2026-03
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Drreddys Laboratories INR 579.35B 573.08B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Richter Gedeon HUF 1.76T 79.96B 2026-03
Sun Pharmaceuticals INR 1.09T 50.79B 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03